Intracranial Pressure (ICP) Monitoring Devices Market Key Players and Opportunities by 2028

[Research Report] The intracranial pressure (ICP) monitoring devices market size is expected to reach US$ 2,433.82 million by 2028 from US$ 1,671.41 million in 2022; it is estimated to record a CAGR of 6.5% from 2023 to 2028.  

ICP devices measure the pressure within the cranium caused by accidents, injuries, and trauma. The ICP monitoring has post-operative and diagnostic importance in patients suffering from cranial damage caused due to stroke, hydrocephalus, or other reasons. ICP devices help surgeons save the lives of patients suffering from these injuries with the help of proper treatment and timely intervention. Generally, there are two types of ICP monitors: one provides ICP data, whereas the other is capable of concurrent cerebrospinal fluid drainage.

The intracranial pressure (ICP) monitoring devices market is segmented on the basis of type, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the competitive landscape analysis of the world's leading market players. 

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Intracranial Pressure (ICP) Monitoring Devices Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights – Intracranial Pressure (ICP) Monitoring Devices Market

Increasing Prevalence of Neurological Diseases

Intracranial pressure (ICP) monitoring is crucial in diagnosing and treating neurological diseases such as subarachnoid and intracerebral hemorrhage, ischemic stroke, hydrocephalus, and meningitis/encephalitis. Bleeding in the brain, tumor, stroke, aneurysm, high blood pressure, or brain infection can lead to fluctuations in intracranial pressure. High ICP can cause headaches, blurred vision, vomiting, and other serious complications such as seizures, neurological damage, and death.

According to the Global Stroke Fact Sheet 2022, there are over 7.6 million new ischemic stroke cases yearly, and over 62% of all incident strokes are ischemic strokes. Around 11% of all ischemic stroke cases occur in patients aged 15–49 years, and more than 58% occur in people under 70. Also, 55% of all ischemic stroke cases occur in women and 45% in men. Moreover, the factsheet has mentioned that 77 million people across the world have survived from ischemic stroke.

The growth of the intracranial pressure (ICP) monitoring devices market is prominently attributed to the increasing prevalence of brain aneurysms across the world and rising number of diagnostic and treatment procedures associated with the brain. According to data published by the Brain Aneurysm Foundation in February 2023, an estimated 6.7 million people in the US suffer from unruptured brain aneurysms, which accounts for around 1 in 50 people. Additionally, an estimated 500,000 deaths are caused due to brain aneurysms across the globe each year.

Thus, the increasing prevalence of neurological diseases drives the growth of the global intracranial pressure (ICP) monitoring devices market.

Offering Insights

The intracranial pressure (ICP) monitoring devices market, by offering, the market is fragmented into products and systems, solutions and platforms, and services. The products and systems segment held the largest market share in 2022 and services is anticipated to register the highest CAGR during the forecast period.

Type Insights

The intracranial pressure (ICP) monitoring devices market, by type, the market is fragmented into invasive and non-invasive. The invasive segment held the largest market share in 2022 and non-invasive is anticipated to register the highest CAGR during the forecast period.

Application Insights

The intracranial pressure (ICP) monitoring devices market, by application, the market is fragmented into traumatic brain injury, Reye’s syndrome, non- traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injury segment held the largest market share in 2022 and hydrocephalus is anticipated to register the highest CAGR during the forecast period.

Product launches and mergers and acquisitions are among the highly adopted strategies by the global intracranial pressure (ICP) monitoring devices market players. A few of the recent key product developments are listed below:

• In December 2019, Raumedic launched a new home-use device, Raumed Home ICP, for monitoring intracranial pressure (ICP). The product was developed for patients suffering from hydrocephalus, a condition where excessive amounts of cerebrospinal fluid (CSF) accumulate in the brain. The device has recently received a CE marking.
• In November 2022, Natus Medical Incorporated announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions. Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.
• In November 2022, IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced it had signed a Sales Agency Agreement with Medtronic to promote its IRRAflow system in the United States with Medtronic.

Intracranial Pressure (ICP) Monitoring Devices Market Regional Insights

The regional trends and factors influencing the Intracranial Pressure (ICP) Monitoring Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Intracranial Pressure (ICP) Monitoring Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Intracranial Pressure (ICP) Monitoring Devices Market Report Scope

Intracranial Pressure (ICP) Monitoring Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Intracranial Pressure (ICP) Monitoring Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Intracranial Pressure (ICP) Monitoring Devices Market are:

1. Natus Medical Inc
2. RAUMEDIC AG
3. Sophysa SA
4. Integra LifeSciences Holdings Corp
5. Medtronic Plc

Disclaimer: The companies listed above are not ranked in any particular order.

Company Profiles – Intracranial Pressure (ICP) Monitoring Devices Market

• Natus Medical Inc
• RAUMEDIC AG
• Sophysa SA
• Integra LifeSciences Holdings Corp
• Medtronic Plc
• Braincare Desenvolvimento e Inovacao Tecnologica SA
• NovaSignal Corp
• Digitimer Ltd
• Longeviti Neuro Solutions LLC
• Spiegelberg GmbH & Co KG.